Product logins

Find logins to all Clarivate products below.


Gastrointestinal Endoscopy Devices | Market Insights | Asia Pacific (Supplemental) | 2020

The Asia Pacific GI endoscopy device market will expand quickly through 2028, primarily driven by the growth of underpenetrated endoscopy procedure volumes as more physicians become trained in endoscopic techniques, and as the Chinese and Indian populations gain greater access to health care in their respective markets. The introduction of robotics in gastrointestinal endoscopy will further improve the scope of market growth over the forecast period.

This Medtech 360 Report provides key market metrics for the GI endoscopy device market in the Asia Pacific region, including country-level data for major countries and aggregate data for the rest of Asia Pacific, across a 10-year period.

Related Medtech Insights Reports

Report
Cardiac Rhythm Management Devices – Market Insights – Asia Pacific
The Asia Pacific CRM device market will register modest growth over the forecast period. Key growth drivers include the rising adoption of premium-priced technologies such as CRT devices, leadless…
Report
Aortic Repair Devices – Market Insights – Asia Pacific
The Asia Pacific aortic repair device market is projected to experience robust growth during the forecast period, fueled by rising endovascular procedure volumes, ongoing innovation in aortic stent…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Europe
The European GI endoscopy device market will be driven primarily by the high incidence of gastric cancer and CRC in the region. Market growth will be supported by nationwide CRC and GI cancer…
Report
Cardiac Rhythm Management Devices | Market Insights | Asia Pacific (Supplemental) | 2025
The Asia Pacific CRM device market will experience modest growth over the forecast period, driven primarily by the increasing volume of ICM procedures and the adoption of premium-priced devices,…
Report
Biosurgical Agents – Market Insights – Asia Pacific
The biosurgical agent market in Asia Pacific will experience modest growth through 2034, driven by rising surgical procedure volumes and expanding use of biosurgical agents across a broader range…